Article Text
Abstract
Introduction
Tetanus is a rare disease in the UK (about 6 cases per year) but it is an important disease world-wide – approximately 500 000 neonates, and similar numbers of adults and children, die from tetanus every year (Dietz et al. 1996). Although much is now known about the pathophysiology of the disease, rather few advances have been made in treatment and the mortality remains high despite modern intensive care facilities. This article will present a general review of the literature concerning tetanus. It will focus on what evidence there is for optimal diagnosis and management, and highlight the key clinical issues that concern the physician when caring for a patient with tetanus
Aetiology
Tetanus is caused by a neurotoxin produced by the bacterium Clostridium tetani (C. tetani), which is an ubiquitous organism found in the soil, and human and animal faeces, throughout the world. The bacteria persist as resilient spores,
Statistics from Altmetric.com
Other content recommended for you
- Clostridial neurotoxins
- Who needs a shot … a review of tetanus immunity in the West of Ireland
- Clostridial diseases of the horse
- Forgotten pathogen: tetanus after gastrointestinal surgery
- Clostridial diseases in farm animals: 2. Histotoxic and neurotoxic diseases
- Tetanus
- Are current UK tetanus prophylaxis procedures for wound management optimal?
- A case of otogenic tetanus
- Pre-emptive treatment for Clostridium tetani: importance of early recognition and treatment in the community
- Return of the old guard: a case of tetanus in an unvaccinated patient